Togo vs World: Access to anti-retroviral drugs, female
Togo
96.0%
in 2024
World
83.0%
in 2024
Togo rank
14th
World rank
15th
Access to anti-retroviral drugs, female over time
- Togo
- World
How they compare
Togo currently reports 96.0% against 83.0% in World, a difference of 13.0%.
That makes Togo's figure about 1.2 times World's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was World ahead.
Togo ranks 14th and World ranks 15th of 141 countries.
Across the 3 decades both report, Togo averaged higher in 2 and World in 1.
Head to head by decade
| Decade | Togo | World | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.6% | 6.5% | 1.9% | World |
| 2010s | 51.6% | 49.3% | 2.3% | Togo |
| 2020s | 91.2% | 78.2% | 13.0% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Togo or World?
- Togo, at 96.0% against 83.0% in World as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Togo and World?
- 13.0%, with Togo ahead.
- How many years of comparable data are there for Togo and World?
- 25 years are reported by both, from 2000 to 2024.
- How do Togo and World rank globally for access to anti-retroviral drugs, female?
- Togo ranks 14th and World ranks 15th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.